Advertisement
Advertisement
U.S. Markets open in 7 hrs 50 mins
S&P Futures
4,020.50 +19.25 (+0.48%) Dow Futures
32,566.00 +132.00 (+0.41%) Nasdaq Futures
12,948.25 +58.00 (+0.45%) Russell 2000 Futures
1,759.50 +11.80 (+0.68%) Crude Oil
69.53 +0.27 (+0.39%) Gold
1,974.60 -9.20 (-0.46%)
COLLEGIUM PHARMAC.DL-,001 (354.MU)
Munich - Munich Delayed Price. Currency in EUR
Follow
At close: 09:04AM CEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 22.60 |
| Open | 21.80 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's Range | 21.80 - 21.80 |
| 52 Week Range | 13.70 - 27.00 |
| Volume | |
| Avg. Volume | 3 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | May 08, 2023 - May 12, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
COLL vs. ZTS: Which Stock Should Value Investors Buy Now?
COLL vs. ZTS: Which Stock Is the Better Value Option?
- Zacks
Pacira's (PCRX) Q4 Earnings Match Estimates, Revenues Fall
Pacira BioSciences (PCRX) reports mixed fourth-quarter financial results, where earnings match estimates, but revenues miss the mark.
- Insider Monkey
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2022 Earnings Call Transcript
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2022 Earnings Call Transcript February 23, 2023 Operator: Greetings, and welcome to the Collegium Pharmaceutical Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. Please note, that this conference call is being […]
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
